These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 33666520)

  • 1. Developing a gene panel for pharmacoresistant epilepsy: a review of epilepsy pharmacogenetics.
    Rodriguez-Acevedo AJ; Gordon LG; Waddell N; Hollway G; Vadlamudi L
    Pharmacogenomics; 2021 Mar; 22(4):225-234. PubMed ID: 33666520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in the development of resistance to antiseizure drugs and their potential as biomarkers in pharmacoresistant epilepsy.
    Bohosova J; Vajcner J; Jabandziev P; Oslejskova H; Slaby O; Aulicka S
    Epilepsia; 2021 Nov; 62(11):2573-2588. PubMed ID: 34486106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine-resistant corneal-kindled mice: A model of pharmacoresistant partial epilepsy for moderate-throughput drug discovery.
    Koneval Z; Knox KM; White HS; Barker-Haliski M
    Epilepsia; 2018 Jun; 59(6):1245-1256. PubMed ID: 29750337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy.
    Wilcox KS; West PJ; Metcalf CS
    Neuropharmacology; 2020 Apr; 166():107811. PubMed ID: 31790717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuing Burden of Refractory Epilepsy.
    Janson MT; Bainbridge JL
    Ann Pharmacother; 2021 Mar; 55(3):406-408. PubMed ID: 32795085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection.
    Verrotti A; Tambucci R; Di Francesco L; Pavone P; Iapadre G; Altobelli E; Matricardi S; Farello G; Belcastro V
    Expert Rev Neurother; 2020 Feb; 20(2):167-173. PubMed ID: 31855066
    [No Abstract]   [Full Text] [Related]  

  • 7. A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy.
    Naimo GD; Guarnaccia M; Sprovieri T; Ungaro C; Conforti FL; Andò S; Cavallaro S
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcification in cerebral parenchyma affects pharmacoresistant epilepsy in tuberous sclerosis.
    Zhang MN; Zou LP; Wang YY; Pang LY; Ma SF; Huang LL; Gao Y; Lu Q; Franz DN
    Seizure; 2018 Aug; 60():86-90. PubMed ID: 29929111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy.
    Barker-Haliski ML; Johnson K; Billingsley P; Huff J; Handy LJ; Khaleel R; Lu Z; Mau MJ; Pruess TH; Rueda C; Saunders G; Underwood TK; Vanegas F; Smith MD; West PJ; Wilcox KS
    Neurochem Res; 2017 Jul; 42(7):1904-1918. PubMed ID: 28303498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could Adult European Pharmacoresistant Epilepsy Patients Be Treated With Higher Doses of Zonisamide?
    Miro J; Jaraba S; Juvany R; Santurino M; Cobo S; Falip M
    Clin Neuropharmacol; 2016; 39(3):121-4. PubMed ID: 26818046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
    Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
    CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mTOR Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy.
    Chi X; Huang C; Li R; Wang W; Wu M; Li J; Zhou D
    J Mol Neurosci; 2017 Apr; 61(4):553-562. PubMed ID: 28229367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Experience With Perampanel for Refractory Pediatric Epilepsy in One Canadian Center.
    Datta AN; Xu Q; Sachedina S; Boelman C; Huh L; Connolly MB
    J Child Neurol; 2017 Aug; 32(9):834-839. PubMed ID: 28511603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy.
    Vanhoof-Villalba SL; Gautier NM; Mishra V; Glasscock E
    Epilepsia; 2018 Feb; 59(2):358-368. PubMed ID: 29265344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources.
    Pérez-Pérez D; Frías-Soria CL; Rocha L
    Epilepsy Behav; 2021 Aug; 121(Pt B):106430. PubMed ID: 31378558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy.
    Srivastava AK; Alex AB; Wilcox KS; White HS
    Epilepsia; 2013 Jul; 54(7):1186-94. PubMed ID: 23750799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy.
    Puligheddu M; Melis M; Pillolla G; Milioli G; Parrino L; Terzano GM; Aroni S; Sagheddu C; Marrosu F; Pistis M; Muntoni AL
    Epilepsia; 2017 Oct; 58(10):1762-1770. PubMed ID: 28766701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy.
    Ishikawa N; Tateishi Y; Tani H; Kobayashi Y; Kobayashi M
    Epilepsy Behav; 2019 May; 94():82-86. PubMed ID: 30897534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the action mechanisms and targets of herbal anticonvulsants highlights opportunities for therapeutic engagement with refractory epilepsy.
    Tabassum S; Shorter S; Ovsepian SV
    J Mol Med (Berl); 2024 Jun; 102(6):761-771. PubMed ID: 38653825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of an HPLC-DAD technique for human plasma concentration monitoring of perampanel and lamotrigine in drug-resistant epileptic patients.
    Sabença R; Bicker J; Silva R; Carona A; Silva A; Santana I; Sales F; Falcão A; Fortuna A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122491. PubMed ID: 33360678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.